Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for interleukin-2 binding (biogroup)
Most Correlated Studies
- Drug target sets for approved compounds
- L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- The Immunological Genome Project - Immune cell lineage differentiation and maturation
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Most Relevant Literature
- Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 re…
- Monoclonal antibodies which differentiate high- and low-affinity binding sites of interleukin-2.
- Effect of selenium on the expression of high affinity interleukin 2 receptors.
- Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor …
Most Relevant Clinical Trials
- Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Le…
- Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblast…
- Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), …
- Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
